Metabolic pathways of diclofenac (DCF) conversion to its oxidative... | Download Scientific Diagram
Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI) - ScienceDirect
Mechanism-Based Inactivation of CYP2C11 by Diclofenac | Drug Metabolism & Disposition
Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism - ScienceDirect
Microorganisms | Free Full-Text | Complete Biodegradation of Diclofenac by New Bacterial Strains: Postulated Pathways and Degrading Enzymes
Proposed primary metabolic pathways for diclofenac in humans. | Download Scientific Diagram
Proposed scheme for the metabolic activation of diclofenac by acyl... | Download Scientific Diagram
Individualizing analgesic prescription. Part II: pharmacogenetics of anti-inflammatory analgesics and co-analgesics | Personalized Medicine
SciELO - Brasil - Effect of iguratimod on diclofenac metabolism by CYP2C9 in rats and human recombinant CYP2C9 yeast cells Effect of iguratimod on diclofenac metabolism by CYP2C9 in rats and human
Bioactivation of Diclofenac in Vitro and in Vivo: Correlation to Electrochemical Studies | Chemical Research in Toxicology
Catalysts | Free Full-Text | Diclofenac Biodegradation by Microorganisms and with Immobilised Systems—A Review
Application Data-Metabolism-Diclofenac | Yecuris FRG: Liver-Humanized Mice & Preclinical Research Services
![Figure 1 from A Novel Bioactivation Pathway for 2-[2-(2,6-Dichlorophenyl)aminophenyl]ethanoic Acid (Diclofenac) Initiated by Cytochrome P450-Mediated Oxidative Decarboxylation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f40773d59bb1468b32e8f82eb5780bc03918192/2-Figure1-1.png "Figure 1 from A Novel Bioactivation Pathway for 2-[2-(2,6-Dichlorophenyl)aminophenyl]ethanoic Acid (Diclofenac) Initiated by Cytochrome P450-Mediated Oxidative Decarboxylation | Semantic Scholar")
Figure 1 from A Novel Bioactivation Pathway for 2-[2-(2,6-Dichlorophenyl)aminophenyl]ethanoic Acid (Diclofenac) Initiated by Cytochrome P450-Mediated Oxidative Decarboxylation | Semantic Scholar
Molecular dynamics investigations of regioselectivity of anionic/aromatic substrates by a family of enzymes: a case study of diclofenac binding in CYP ... - Physical Chemistry Chemical Physics (RSC Publishing) DOI:10.1039/C6CP01128D
Formation of a Toxic Quinoneimine Metabolite from Diclofenac: A Quantum Chemical Study | Bentham Science
Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity | ACS Omega
Diclofenac metabolism in the mouse: Novel in vivo metabolites identified by high performance liquid chromatography coupled to li
Roles of diclofenac and its metabolites in immune activation associated with acute hepatotoxicity in TgCYP3A4/hPXR-humanized mice - ScienceDirect
![PDF] MECHANISM-BASED INACTIVATION OF CYP 2 C 11 BY DICLOFENAC | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4b112e032274098d048194027a1c92d728301017/2-Figure1-1.png "PDF] MECHANISM-BASED INACTIVATION OF CYP 2 C 11 BY DICLOFENAC | Semantic Scholar")
PDF] MECHANISM-BASED INACTIVATION OF CYP 2 C 11 BY DICLOFENAC | Semantic Scholar
Diclofenac - an overview | ScienceDirect Topics
Hepatic Clearance of Reactive Glucuronide Metabolites of Diclofenac in the Mouse Is Dependent on Multiple ATP-Binding Cassette Efflux Transporters | Molecular Pharmacology
Diclofenac transport and metabolism (adopted from PharmGKB pathway... | Download Scientific Diagram
Cytochrome P450 3A4-Mediated Interaction of Diclofenac and Quinidine | Drug Metabolism & Disposition
Photo-Fenton Degradation of Diclofenac: Identification of Main Intermediates and Degradation Pathway | Environmental Science & Technology
Proposed Bioactivation Pathway of the Anti-Inflammatory Agent Diclofenac. | Download Scientific Diagram
STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE | Drug Metabolism & Disposition
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
